Clinical Scorecard: Machine Learning Alone Won’t Take Vibrational Spectroscopy Into the Clinic

At a Glance

Key Highlights

• Inconsistent analytical practices hinder clinical adoption more than model performance.
• Preprocessing decisions can significantly affect classification results.
• Small, institution-specific datasets increase the risk of overfitting.
• Hybrid approaches combining machine learning with chemically meaningful inputs are proposed.
• Standardized reporting and external validation are critical for clinical application.

Guideline-Based Recommendations

Diagnosis

• Utilize vibrational spectroscopy for tumor classification and pathogen identification.

Management

• Implement standardized reporting of spectral data and preprocessing methods.

Monitoring & Follow-up

• Validate models under realistic clinical conditions and inter-instrument variation.

Risks

• High classification accuracy on small datasets may not translate to diverse clinical settings.

Patient & Prescribing Data

Patients in need of rapid diagnostics and treatment monitoring.

Potential applications include antimicrobial resistance testing and tumor-margin assessment.

Clinical Best Practices

• Ensure reproducibility and transparency in analytical methods.
• Develop openly available reference datasets for broader validation.
• Focus on addressing specific unmet clinical needs rather than solely on accuracy.

Related Resources & Content

• Microchemical Journal Review